山东大学耳鼻喉眼学报 ›› 2022, Vol. 36 ›› Issue (6): 96-100.doi: 10.6040/j.issn.1673-3770.0.2021.582

• 论著 • 上一篇    下一篇

面鼻眶脑毛霉病1例并文献复习

宋华荣1,唐光华2,朱任良3   

  1. 1.广州中医药大学 第二临床医学院, 广东 广州 510405;
    2.广东省中医院 急诊科, 广东 广州 510120;
    3.广东省中医院 耳鼻咽喉头颈科, 广东 广州 510120
  • 发布日期:2022-12-07
  • 通讯作者: 朱任良. E-mail:entzrl@126.com

A case report of rhino-orbitocerebral mucormycosis

SONG Huarong1, TANG Guanghua2, ZHU Renliang3   

  1. 1. The Second Clinical Medical College, Guangzhou University of Traditional Chinese Medicine, Guangzhou 510405, Guangdong, China;
    2. Department of Emergency, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou 510120, Guangdong, China;
    3. Department of Otorhinolaryngology & Head and Neck Surgery, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou 510120, Guangdong, China
  • Published:2022-12-07

摘要: 目的 总结1例面鼻眶脑毛霉病(ROCM)的诊疗经验,提高对该疾病的认识。 方法 回顾性分析1例ROCM患者的临床病例资料,结合相关文献进行讨论总结。 结果 本例患者以口腔牙齿酸痛为首发表现,既往糖尿病血糖控制差,完善相关检查,实验室确诊为根霉菌属感染的ROCM病,经控制基础疾病、抗真菌、手术治疗等,患者最终临床结局死亡。 结论 ROCM病多见于未控制的糖尿病患者,临床表现多样,典型表现为局部皮肤或黏膜焦痂样坏死,影像学检查无特异性表现,病理及真菌培养为其诊断金标准。早期诊断,及早有效的抗真菌、基础疾病治疗、手术治疗是诊治关键。

关键词: 毛霉病, 鼻脑型毛霉病, 根霉菌, 糖尿病, 牙齿酸痛

Abstract: Objective This study aimed summarize the diagnosis and treatment experience in the case of rhino-orbitocerebral mucormycosis(ROCM)and improve the understanding of the disease. Methods The clinical case data of a patient with ROCM were retrospectively reviewed and summarized in combination with relevant literature. Results This patient's first manifestation was oral dental soreness, with poor glycemic control previous diabetes. The relevant examinations were improved, and the diagnosis of ROCM due to Rhizopus infection was confirmed by the laboratory. After controlling the underlying disease, antifungal and surgical operations, the patient final clinical outcome was death. Conclusion ROCM mostly is seen in patients with uncontrolled diabetes. Its clinical presentation is diverse, and typically involves localized cutaneous or mucosal eschar necrosis. There was no specific manifestation in the imaging examination. Pathology and fungal culture were the gold standard for diagnosis. Early diagnosis and effective treatment, such as antifungal therapy, basic disease treatment, and surgical treatment are the key to diagnosis and treatment.

Key words: Mucormycosis, Rhino-orbitocerebral mucormycosis, Rhizopus, Diabetes, Toothache

中图分类号: 

  • R762
[1] 李孟达,叶俊杰.鼻-眼-脑型毛霉菌病的研究现状[J]. 中华眼科杂志, 2019, 55(8): 629-633. doi:10.3760/cma.j.issn.0412-4081.2019.08.017. LI Mengda, YE Junjie. Advance study of rhinocerebralmucormycosis[J]. Chinese Journal of Ophthalmology, 2019, 55(8):629-633. doi:10.3760/cma.j.issn.0412-4081.2019.08.017.
[2] 孙凌月, 余进, 李若瑜, 等. 糖尿病合并肺毛霉病1例[J]. 中国真菌学杂志, 2020, 15(6): 371-373. doi:10.3969/j.issn.1673-3827.2020.06.012.
[3] Reid G, Lynch JP III, Fishbein MC, et al. Mucormycosis[J]. Semin Respir Crit Care Med, 2020, 41(1): 99-114. doi:10.1055/s-0039-3401992.
[4] Singh V, Sharma B, Sen R, et al. Rhinocerebral mucormycosis: a diagnostic challenge and therapeutic dilemma in immunocompetent host[J]. J Oral Maxillofac Surg, 2012, 70(6): 1369-1375. doi:10.1016/j.joms.2011.06.209.
[5] 郑华东, 杨渭临, 崔大江, 等. 2型糖尿病合并毛霉菌病的临床分析[J]. 西安交通大学学报(医学版), 2016, 37(5): 703-707. doi:10.7652/jdyxb201605018. ZHENG Huadong, YANG Weilin, CUI Dajiang, et al. Clinical analysis of type 2 diabetes mellitus-associated mucormycosis[J]. Journal of Xi'an Jiaotong University(Medical Sciences), 2016, 37(5): 703-707. doi:10.7652/jdyxb201605018.
[6] 刘海蔚, 高勇义, 陈道雄, 等. 糖尿病合并毛霉菌病研究进展[J]. 中国热带医学, 2014, 14(11): 1414-1416. doi:10.13604/j.cnki.46-1064/r.2014.11.043. LIU Haiwei, GAO Yongyi, CHEN Daoxiong, et al. Research progress of diabete patients complicated with mucormycosis[J]. China Tropical Medicine, 2014, 14(11): 1414-1416. doi:10.13604/j.cnki.46-1064/r.2014.11.043.
[7] 黄方,周小平.口腔颌面颈部多间隙感染63例[J]. 山东大学耳鼻喉眼学报, 2020, 34(6): 104-107. doi:10.6040/j.issn.1673-3770.0.2019.559. HUANG Fang, ZHOU Xiaoping. Clinical analysis of 63 cases with multiple oral, maxillofacial, and neck infections[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(6): 104-107. doi:10.6040/j.issn.1673-3770.0.2019.559.
[8] 冯亚辉, 李秀国,史冬梅. 鼻脑型毛霉病病原菌及发病机制研究进展[J]. 中国麻风皮肤病杂志, 2020,36(12): 754-759. doi:10.12144/zgmfskin202012754. FENG Yahui, LI Xiuguo, SHI Dongmei. Update of pathogen and pathogenesis of rhinocerebral mucormycosis[J]. China journal of Leprosy and Skin Diseases, 2020, 36(12): 754-759. doi:10.12144/zgmfskin202012754.
[9] 邹寄林, 邱涛, 周江桥, 等. 肾移植术后肺毛霉菌感染2例并文献复习[J]. 实用器官移植电子杂志, 2021, 9(2): 152-155. doi:10.3969/j.issn.2095-5332.2021.02.015.
[10] 孙逊, 肖烨, 迟海燕, 等. 糖尿病并发感染临床研究进展[J]. 青岛大学医学院学报, 2017, 53(4): 499-502. doi:10.13361/j.qdyxy.201704039.
[11] Ibrahim AS, Spellberg B, Walsh TJ, et al. Pathogenesis of mucormycosis[J]. Clin Infect Dis, 2012, 54(Suppl 1): S16-S22. doi:10.1093/cid/cir865.
[12] Prakash H, Chakrabarti A. Global epidemiology of mucormycosis[J]. J Fungi(Basel), 2019, 5(1): 26. doi:10.3390/jof5010026.
[13] 梁官钊,刘维达. 2019年欧洲毛霉病诊疗指南解读[J]. 中国真菌学杂志, 2021,16(2): 116-120.
[14] Sreshta K, Dave TV, Varma DR, et al. Magnetic resonance imaging in rhino-orbital-cerebral mucormycosis[J]. Indian J Ophthalmol, 2021, 69(7): 1915-1927. doi:10.4103/ijo.IJO_1439_21.
[15] Lam SC, Yuen HKL. Management of bilateral rhino-orbital cerebral mucormycosis[J]. Hong Kong Med J, 2019, 25(5): 408-409. doi:10.12809/hkmj187588.
[16] 沈敏, 杨鑫, 黄梅. 糖尿病合并鼻眶脑型毛霉菌病1例诊治体会[J]. 内科急危重症杂志, 2019, 25(4): 345-347, 352. doi:10.11768/nkjwzzzz20190425.
[17] Maeda Y, Toda K, Toi S, et al. Diagnostic utility of polymerase chain reaction for paraffin-embedded sinus specimens for rhinocerebral mucormycosis complicated by internal carotid artery thrombosis and cerebral infarction[J]. Intern Med, 2021, 60(16): 2683-2686. doi:10.2169/internalmedicine.6809-20.
[18] Brunet K, Rammaert B. Mucormycosis treatment: Recommendations, latest advances, and perspectives[J]. J Mycol Med, 2020, 30(3): 101007. doi:10.1016/j.mycmed.2020.101007.
[19] 杨政,刘正印.毛霉菌病的诊断和治疗进展[J]. 中华内科杂志, 2021, 60(11): 1013-1016. doi:10.3760/cma.j.cn112138-20210224-00159. YANG Zheng, LIU Zhengyin. Recent advances in the diagnosis and treatment of mucormycosis[J]. Chinese Journal of Internal Medicine, 2021, 60(11): 1013-1016. doi:10.3760/cma.j.cn112138-20210224-00159.
[20] Cornely OA, Alastruey-Izquierdo A, Arenz D, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium[J]. Lancet Infect Dis, 2019, 19(12): e405-e421. doi:10.1016/S1473-3099(19)30312-3.
[21] Tissot F, Agrawal S, Pagano L, et al. ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients[J]. Haematologica, 2017, 102(3): 433-444. doi:10.3324/haematol.2016.152900.
[22] 黄鹂, 徐寅鹏, 李方, 等. 1例两性霉素B致毛霉菌感染患者药物性肝损伤的病例分析[J]. 中南药学, 2021, 19(2): 356-359. doi:10.7539/j.issn.1672-2981.2021.02.033. HUANG Li, XU Yinpeng, LI Fang, et al. Drug-induced liver injury in a patient with amphotericin B-induced Mucor infection[J]. Central South Pharmacy, 2021, 19(2): 356-359. doi:10.7539/j.issn.1672-2981.2021.02.033.
[23] 杨永华. 2型糖尿病患者伴有毛霉菌肺炎临床治疗的药学监护[J]. 抗感染药学, 2019, 16(3): 473-475. doi:10.13493/j.issn.1672-7878.2019.03-035. YANG Yonghua. Pharmaceutical Care of Clinical Medication in Type 2 Diabetes Mellitus Patients with Mucormycosis Pneumonia[J]. Anti-Infection Pharmacy, 2019, 16(3): 473-475. doi:10.13493/j.issn.1672-7878.2019.03-035.
[24] Galletti B, Freni F, Meduri A, et al. Rhino-orbito-cerebral mucormycosis in diabetic disease mucormycosis in diabetic disease[J]. J Craniofacial Surg, 2020, 31(4): e321-e324. doi:10.1097/SCS.0000000000006191.
[25] 崔世磊, 江汉秋, 孔秀云, 等. 累及脑神经的鼻脑型毛霉菌病八例临床特点分析[J]. 中国现代神经疾病杂志, 2021, 21(5): 364-370. doi:10.3969/j.issn.1672-6731.2021.05.006. CUI Shilei, JIANG Hanqiu, KONG Xiuyun, et al. Clinical features of rhinocerebral mucormycosis with cranial nerves involvement: report of 8 cases[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2021, 21(5): 364-370. doi:10.3969/j.issn.1672-6731.2021.05.006.
[1] 赵娟,焦万珍,赵博军. UWFSS-OCTA检测糖尿病视网膜病变微循环的变化[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 80-86.
[2] 朱明琼,李征,刘茹,田涛,彭婧利,吕倩怡,谭华霞. 基于OCT/OCTA的AI筛查系统在抗VEGF治疗糖尿病性黄斑水肿患者效果评价中的应用[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 68-73.
[3] 孙庆祝,沈健,陈星,吴雁冰,曾论. 代谢指标在预测糖尿病性黄斑水肿患者雷珠单抗疗效中的作用[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 74-81.
[4] 高琳,何金梅,杨明祎. 糖尿病视网膜病变患者血清Sestrin2和NADPH氧化酶2水平与眼底病变的相关性[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 113-117.
[5] 辛梦,纪芳,代春华,张靖,刘澍. 医用透明质酸钠与平衡盐溶液在微创玻璃体手术中对眼表保护的影响[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 58-65.
[6] 沈嘉琪,李潇飒,毕燕龙,张敬法. 人工智能在DME筛查、诊断和预后中的应用[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 153-159.
[7] 鲍莹,刘志高,姜鹏飞,崔文轩,郑晓霞,杨梦瑶,司明威,王玉,王红. 康柏西普治疗糖尿病合并CRVO-ME高反射点的临床观察[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 55-60.
[8] 常威威,焦万珍,崔艳艳,赵杰,刘兆强,赵博军. 糖尿病性黄斑缺血的研究进展[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 130-136.
[9] 周静琳,李金香,曾琦. 577 nm阈值下微脉冲激光联合抗VEGF药物治疗难治性糖尿病性黄斑水肿的疗效观察[J]. 山东大学耳鼻喉眼学报, 2024, 38(2): 18-25.
[10] 何静,雷春燕,张美霞. 糖化血红蛋白变异指数与糖尿病视网膜病变严重程度的相关性研究[J]. 山东大学耳鼻喉眼学报, 2024, 38(2): 34-40.
[11] 李淑婷,赵慧,司明威,崔文轩,杨梦瑶,王红. 无植物性外伤史患者感染真菌性眼内炎1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2024, 38(2): 103-108.
[12] 伦英俊,陈晨,高宏程,范清琳,邰仁清. TLR4/NF-κB通道在糖尿病视网膜病变中的作用[J]. 山东大学耳鼻喉眼学报, 2024, 38(2): 163-168.
[13] 卢淦,邓玉琴,陶泽璋. 过敏性疾病与糖尿病的相关性及潜在关联机制[J]. 山东大学耳鼻喉眼学报, 2023, 37(5): 215-222.
[14] 唐慧新,李景景,邹红. 阈值下微脉冲激光光凝作用机制及临床应用[J]. 山东大学耳鼻喉眼学报, 2023, 37(3): 143-148.
[15] 刘通,林玮,冯萌,杨依,刘婷婷,张敏. 基于网络药理学分析小檗碱在免疫微环境中对糖尿病视网膜病变的作用及实验验证[J]. 山东大学耳鼻喉眼学报, 2023, 37(1): 94-104.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!